World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 8 January 2024
Main ID:  ISRCTN17263619
Date of registration: 15/03/2017
Prospective Registration: No
Primary sponsor: County Council of Västerbotten (Västerbottens läns landsting)
Public title: Does muscle strength and abdominal wall function improve with weight loss after gastric bypass?
Scientific title: Does muscle strength and abdominal wall function improve with weight loss after gastric bypass? A clinical observational study
Date of first enrolment: 30/09/2016
Target sample size: 100
Recruitment status: Ongoing
URL:  https://www.isrctn.com/ISRCTN17263619
Study type:  Observational
Study design:  Clinical observational study and semi-structured interviews with qualitative content analysis (Treatment)  
Phase:  Not Applicable
Countries of recruitment
Sweden
Contacts
Name: Ulf    Gunnarsson
Address:  Department of Surgery and Perioperative Sciences Umeå University 901 87 Umeå Sweden
Telephone: +46 (0)90 7852909
Email: Ulf.Gunnarsson@umu.se
Affiliation: 
Name: Jeff    Wennerlund
Address:  Department of Surgery and Orthopedics Lycksele Hospital 92182 Lycksele Sweden
Telephone: +46 (0)950 39124
Email: Jeff.Wennerlund@umu.se
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Patients eligible for primary laparoscopic gastric bypass
2. All patients undergoing primary laparoscopic gastric bypass at Lycksele Hospital are eligible for recruitment
3. Patients undergoing surgery in Uppsala are eligible for collection of blood and tissue samples only
4. All ages

Exclusion criteria: If, after inclusion, no or different surgery is planned

Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Obesity, weight loss, muscle strength
Nutritional, Metabolic, Endocrine
Obesity
Intervention(s)
Current interventions as of 13/12/2023:
Blood samples are collected to analyze matrix metalloproteinases, hyaluron och associated biomarkers before surgery, as well as 1 month, 3 months, 6 months, plus 2 and 3 years after. Abdominal wall muscle and fascia biopsies are also collected during surgery for analysis. Abdominal wall and thigh strength are measured with the use of BioDex System 3 before, 6 months, and 3-6 years after gastric bypass. Physical ability and abdominal wall function are also measured using the Ventral Hernia Pain Questionnaire (VHPQ), International Physical Ability Questionnaire (IPAQ) and Visual Analog Scale for abdominal wall function (VAS), all once before, 6 months and 3-6 years after surgery.

Two qualitative interview studies using Qualitative Content Analysis designed to capture experiences of change of bodily function after weight loss induced by gastric bypass surgery. The first study will take place one to three years postoperatively and focus on the changes in physical activity. A later interview study 3 to 6 years after surgery will focus on abdominal wall function.

______

Previous interventions as of 03/03/2022:

Blood samples are collected to analyze matrix metalloproteinases before surgery, as well as 2 weeks, 1 month, 3 months, 6 months, and 2 years after. Abdominal wall muscle and fascia biopsies are collected during surgery for analysis of matrix metalloproteinases. Abdominal wall and thigh strength are measured with the use of BioDex System 3 before and 6 months after gastric bypass. Physical ability and abdominal wall function are also measured using the Ventral Hernia Pain Questionnaire (VHPQ), International Physical Ability Questionnaire (IPAQ) and Visual Analog Scale for abdominal wall function (VAS), all once before and once
Primary Outcome(s)
Current primary outcome measure as of 13/12/2023:
1. Matrix metalloproteinases, hyaluron and associated biomarkers measured from blood samples taken at baseline (pre-operatively) and 1 month, 3 months, 6 months, and 2 and 3 years postoperatively
2. Abdominal wall and thigh muscle strength, measured with the BioDex System 3 at baseline (pre-operatively), 6 months and 3-6 years postoperatively
3. Physical ability and abdominal wall function, measured using the Ventral Hernia Pain Questionnaire (VHPQ), International Physical Activity Questionnaire (IPAQ), and Visual Analog Scale (VAS) for abdominal wall function at baseline (pre-operatively), 6 months and 3-6 years postoperatively
4. Semi-structured interviews describing the change in muscle strength, physical activity ability and abdominal wall function after gastric bypass surgery

_____

Previous primary outcome measure as of 03/03/2022:

1. Matrix metalloproteinases, measured from blood samples taken at baseline (pre-operatively) and 2 weeks, 1 month, 3 months, 6 months, and 2 years postoperatively
2. Abdominal wall and thigh muscle strength, measured with the BioDex System 3 at baseline (pre-operatively) and 6 months postoperatively
3. Physical ability and abdominal wall function, measured using the Ventral Hernia Pain Questionnaire (VHPQ), International Physical Activity Questionnaire (IPAQ), and Visual Analog Scale (VAS) for abdominal wall function at baseline (pre-operatively) and 6 months postoperatively
4. Semi-structured interviews describing the change in muscle strength and physical activity ability after gastric bypass surgery

_____

Previous primary outcome measure as of 21/04/2020:

1. Matrix metalloproteinases, measured from blood samples taken at baseline (pre-operatively) and 2 weeks, 1 month, 3 months, 6 months, and 2 years postoperatively
2. Abdominal wall and thigh muscle strength, measured with the BioDex System 3 at baseline (pre-operatively) and 6 months post-operatively
3. Physical ability and abdominal wall function, measured using the Ventral Hernia Pain Questionnaire (VHPQ), International Physical Activity Questionnaire (IPAQ), and Visual Analog Scale (VAS) for abdominal wall function at baseline (pre-operatively) and 6 months postoperatively

_____

Previous primary outcome measure:

1. Matrix metalloproteinases, measured from blood samples taken at baseline (pre-operatively) and 2 weeks, 1 month, 3 months and 6 months postoperatively
2. Abdominal wall and thigh muscle strength, measured with the BioDex System 3 at baseline (pre-operatively) and 6 months post-operatively
3. Physical ability and abdominal wall function, measured using the Ventral Hernia Pain Questionnaire (VHPQ), International Physical Activity Questionnaire (IPAQ), and Visual Analog Scale (VAS) for abdominal wall function at baseline (pre-operatively) and 6 months postoperatively
Secondary Outcome(s)
There are no secondary outcome measures
Secondary ID(s)
GUMP
Nil known
Source(s) of Monetary Support
Umeå Universitet
Secondary Sponsor(s)
Ethics review
Status:
Approval date:
Contact:
Old ethics approval format; Approved 10/01/2016, Regional Ethics Review Board, Umeå (Samverkanshuset, Umeå University, Umeå, 901 87, Sweden; +46 (0)10-4750800; registrator@etikprovning.se), ref: 2015/367-31 Since this approval, this regional board has been replaced by a national agency, the Swedish Ethical Review Authority
Results
Results available:
Date Posted:
Date Completed: 31/12/2027
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history